Tetraphase Pharmaceuticals, Inc. (TTPH)
(Delayed Data from NSDQ)
$1.06 USD
+0.07 (7.07%)
Updated May 3, 2019 04:00 PM ET
After-Market: $1.05 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[TTPH]
Reports for Purchase
Showing records 1 - 20 ( 123 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
We''re Dizzy...And Is Someone at Tetraphase a Master Negotiator?
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
4Q19 Recap: XERAVA Begins to Gain Traction but Long Road Ahead to Profitability
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
3Q19 Recap XERAVA Growth Would Help, But More Drastic Moves Are Needed
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Industry: Medical - Drugs
Recent Moves Buy Some Time, But Next Two Quarters Are Critical; Maintain Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E